Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin‐like growth factor (IGF)‐I expression in bronchial asthma

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Clinical and Experimental Allergy

• Publication date

  1998-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2222.1998.00277.xPMID 9645593
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation.

  1996cited by this paper
• Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects.

  1995cited by this paper
• Enhanced insulin-like growth factor molecules in idiopathic pulmonary fibrosis.

  1995cited by this paper
• Transcriptional repression of insulin-like growth factor I by glucocorticoids in rat bone cells.

  1995cited by this paper
• Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma.

  1994cited by this paper
• Platelet-derived growth factor and its receptor in lungs from patients with asthma and chronic airflow obstruction.

  1994cited by this paper
• Glucocorticoid regulation of insulin-like growth factor-binding protein expression in normal human osteoblast-like cells.

  1994cited by this paper
• Transforming growth factor beta 1 gene expression in human airways.

  1994cited by this paper
• What role for inhaled steroids in chronic asthma?

  1993cited by this paper
• Airway mucosal inflammation even in patients with newly diagnosed asthma.

  1993cited by this paper
• Platelet-derived growth factor-β mRNA in human alveolar macrophages in vivo in asthma

  1993cited by this paper
• Mast cells and biogenic amines in radiation-induced pulmonary fibrosis.

  1993cited by this paper
• The T cell and the airway's fibrotic response in asthma.

  1993cited by this paper
• Dexamethasone-induced increase in platelet-derived growth factor (B) mRNA in human alveolar macrophages and myelomonocytic HL60 macrophage-like cells.

  1992cited by this paper
• Cytokines of the lung.

  1992cited by this paper
• Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study.

  1992cited by this paper
• Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls.

  1992cited by this paper
• Asthma: a disease remodeling the airways

  1992cited by this paper
• A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial.

  1992cited by this paper
• Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor.

  1992cited by this paper
• Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1).

  1992cited by this paper
• Spontaneous increase of transforming growth factor beta production by bronchoalveolar mononuclear cells of patients with systemic autoimmune diseases affecting the lung.

  1992cited by this paper
• Interactions between steroid hormones and insulin-like growth factor-I in rabbit chondrocytes.

  1991cited by this paper
• Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis.

  1991cited by this paper
• Eosinophils adhere to and stimulate replication of lung fibroblasts ‘in vitro’

  1991cited by this paper
• Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells.

  1990cited by this paper
• Myofibroblasts and subepithelial fibrosis in bronchial asthma.

  1990cited by this paper
• Eosinophilic inflammation in asthma.

  1990cited by this paper
• Mucosal inflammation in asthma.

  1990cited by this paper
• Cellular events in the bronchi in mild asthma and after bronchial provocation.

  1989cited by this paper
• Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation

  1989cited by this paper
• Immunodetection and quantitation of the two forms of transforming growth factor‐beta (TGF‐β1 and TGF‐β2) secreted by cells in culture

  1989cited by this paper
• Subepithelial fibrosis in the bronchi of asthmatics.

  1989cited by this paper
• Production and action of insulin-like growth factor I/somatomedin C in primary cultures of fetal lung fibroblasts.

  1989cited by this paper
• Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes

  1989cited by this paper
• Isolation and characterization of lung mast cells from rats with bleomycin-induced pulmonary fibrosis.

  1989cited by this paper
• Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity.

  1989cited by this paper
• Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture.

  1989cited by this paper
• Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids.

  1988cited by this paper
• A single polypeptide acts both as the beta subunit of prolyl 4-hydroxylase and as a protein disulfide-isomerase.

  1987cited by this paper
• Somatomedin C/insulin-like growth factor I production by human fetal lung tissue maintained in vitro.

  1987cited by this paper
• Identification of Somatomedin/Insulin-Like Growth Factor Immunoreactive Cells in the Human Fetus

  1987cited by this paper
• Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis.

  1987cited by this paper
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986.

  1987cited by this paper
• Impaired Synergism between Somatomedin C/Insulin-Like Growth Factor I and Dexamethasone in the Growth of Fibroblasts from a Patient with Insulin Resistance

  1987cited by this paper
• Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus.

  1987cited by this paper
• Statistical methods for assessing agreement between two methods of clinical measurement.

  1986cited by this paper
• Damage of the airway epithelium and bronchial reactivity in patients with asthma.

  1985cited by this paper
• Monoclonal antibodies to human prolyl 4-hydroxylase.

  1984cited by this paper
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

  1981cited by this paper
• Direct-writing recorder of the dose-response curves of the airway to methacholine. Clinical application.

  1981cited by this paper
• Purification of somatomedin-C from human plasma: chemical and biological properties, partial sequence analysis, and relationship to other somatomedins.

  1980cited by this paper
• Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders.

  1979cited by this paper
• AKUFO AND IBARAPA.

  1965cited by this paper

• The New Paradigm: The Role of Proteins and Triggers in the Evolution of Allergic Asthma

  2024cites this paper
• Higher levels of insulin‐like growth factor‐1 in cord blood associate with risk of asthma at age 3

  2023cites this paper
• Circulating insulin-like growth factor-1 and risk of lung diseases: A Mendelian randomization analysis

  2023cites this paper
• Evaluation serum levels of Insulin Growth Factor-1 (IGF-1) and its association with clinical parameters in severe COVID-19

  2022cites this paper
• MicroRNAs in Asthma and COPD; from biomarkers to regulators of disease pathogenesis

  2022cites this paper
• Circular RNA ERBB2 Contributes to Proliferation and Migration of Airway Smooth Muscle Cells via miR-98-5p/IGF1R Signaling in Asthma

  2021cites this paper
• Metabolism of Epithelial Cells in Health and Allergic Disease: Collegium Internationale Allergologicum Update 2021

  2021cites this paper
• Translational Analysis of Moderate to Severe Asthma GWAS Signals Into Candidate Causal Genes and Their Functional, Tissue-Dependent and Disease-Related Associations

  2021cites this paper
• Alveolar Epithelial Cells Promote IGF-1 Production by Alveolar Macrophages Through TGF-β to Suppress Endogenous Inflammatory Signals

  2020cites this paper
• Leonurus sibiricus root extracts decrease airway remodeling markers expression in fibroblasts

  2020cites this paper
• A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)

  2020cites this paper
• miR-223: A Key Regulator in the Innate Immune Response in Asthma and COPD

  2020cites this paper
• [New approaches of inhaled steroid asthma management in mild to moderate asthma].

  2019cites this paper
• As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?

  2019cites this paper
• Insulin‑like growth factor 1 inhibits phagocytosis of alveolar epithelial cells in asthmatic mice.

  2019cites this paper
• Insulin-Like Growth Factor 1 Regulates Acute Inflammatory Lung Injury Mediated by Influenza Virus Infection

  2019cites this paper
• Airway structural remodelling in asthma: Functional relevance and suitability as a target for therapy

  2018cites this paper
• Insulin-Like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases

  2018cites this paper
• Airway remodeling in asthma: what really matters

  2017cites this paper
• High serum levels of IGF-I and IGFBP3 may increase comorbidity risk for asthmatic patients.

  2017cites this paper
• Characterization of the acute inflammatory profile and resolution of airway inflammation after Igf1r-gene targeting in a murine model of HDM-induced asthma

  2017cites this paper
• Targeting the IL-33/ST2 pathway in asthma : implications for development, exacerbation and treatment

  2017cites this paper
• Attenuated airway hyperresponsiveness and mucus secretion in HDM‐exposed Igf1r‐deficient mice

  2017cites this paper
• Chronic stress impairs the local immune response during cutaneous repair in gilthead sea bream (Sparus aurata, L.)

  2017cites this paper
• INVITED REVIEW SERIES: UNRAVELLING THE MANY FACES OF COPD TO OPTIMIZE ITS CARE AND OUTCOMES

  2016cites this paper
• The Role of the T lymphocytes and Remodeling in Asthma

  2016cites this paper
• Therapeutic implication of genetic variants of IL13 and STAT4 in airway remodelling with bronchial asthma

  2016cites this paper
• MechanismsRemodeling in Asthma: Therapeutic Implications of

  2015cites this paper
• Clinical, physiological, and radiological features of asthma–chronic obstructive pulmonary disease overlap syndrome

  2015cites this paper
• Gender differences in the relationship between body mass index (BMI) changes and the prevalence and severity of wheezing and asthma in the first year of life.

  2015cites this paper
• Potential antiasthmatic, antihistaminic and antidiarrhoeal effects of cryptolepine, the major alkaloid of cryptolepis sanguinolenta (lindl.) schltr (periplocaceae), in experimental animals.

  2015cites this paper
• Characterization of a novel model incorporating airway epithelial damage and related fibrosis to the pathogenesis of asthma

  2014cites this paper
• Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma.

  2014cites this paper
• Asthma Therapy and Its Effect on Airway Remodelling

  2014cites this paper
• The Properties of Circulating Fibrocytes in Severe Asthma

  2014cites this paper
• Potential Involvement of IL-17F in Asthma

  2014cites this paper
• Thymic stromal lymphopoietin and its downstream networks in severe asthma

  2013cites this paper
• Antileukotriene Reverts the Early Effects of Inflammatory Response of Distal Parenchyma in Experimental Chronic Allergic Inflammation

  2013cites this paper
• Comparison of TNF antagonism by etanercept and dexamethasone on airway epithelium and remodeling in an experimental model of asthma.

  2013cites this paper
• Mucosal remodeling and reversibility in chronic rhinosinusitis

  2013cites this paper
• The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation

  2013cites this paper
• Composition of the airway smooth muscle layer in airway disease: implications for airway function and disease pathogenesis

  2013cites this paper
• Is low dose inhaled corticosteroid therapy as effective for inflammation and remodeling in asthma? A randomized, parallel group study

  2012influential citation
• Acute inflammation induces insulin-like growth factor-1 to mediate Bcl-2 and Muc5ac expression in airway epithelial cells.

  2012cites this paper
• Recombinant IGFBP‐3 inhibits allergic lung inflammation, VEGF production, and vascular leak in a mouse model of asthma

  2012cites this paper
• Estudo da ativação eosinofílica e de matriz extracelular de tecido pulmonar periférico em cobaias com inflamação alérgica pulmonar: efeitos do tratamento com dexametasona e antagonista do receptor do cisteinil- leucotrieno D4

  2012cites this paper
• Insulin-like Growth Factor-binding Protein-3 (IGFBP-3) Blocks the Effects of Asthma by Negatively Regulating NF-κB Signaling through IGFBP-3R-mediated Activation of Caspases*♦

  2011cites this paper
• What effect does asthma treatment have on airway remodeling? Current perspectives.

  2011cites this paper
• Transcriptional regulation of inflammatory genes associated with severe asthma.

  2011cites this paper
• Effect of genetic variation of IL-13 on airway remodeling in bronchial asthma.

  2011cites this paper
• Airway Measurement for Airway Remodeling Defined by Post-Bronchodilator FEV1/FVC in Asthma: Investigation Using Inspiration-Expiration Computed Tomography

  2010cites this paper
• Morphological and Molecular Characteristics of “Difficult” Asthma

  2010cites this paper
• Montelukast added to fluticasone propionate does not alter inflammation or outcomes.

  2010cites this paper
• Induction of insulin‐like growth factor‐I by interleukin‐17F in bronchial epithelial cells

  2010cites this paper
• Recent findings on the pathogenesis of bronchial asthma. Part II. The role of hormonal predisposition, environmental influences and conditioning leading to bronchial asthma.

  2009cites this paper
• Role of insulin-like growth factor binding protein-3 in allergic airway remodeling.

  2009cites this paper
• Fibroblasts as matrix modulating cells in asthma and COPD

  2009cites this paper
• [Pathomorphological characteristics of unstable bronchial asthma (brittle phenotype)].

  2008cites this paper
• Airway Inflammation and Bronchial Hyperresponsiveness in Elite Cross-Country Skiers and in Patients with Newly Diagnosed Asthma : A Bronchial Biopsy Study

  2008cites this paper
• Combined budesonide/formoterol therapy in conjunction with allergen avoidance ameliorates house dust mite-induced airway remodeling and dysfunction.

  2008cites this paper
• Insights into Early Treatment of Mild Asthma

  2007cites this paper
• Insights into early treatment of mild asthma: do inhaled corticosteroids make a difference?

  2007cites this paper
• Airway Remodeling in Asthma and Irreversible Airflow Limitation ― ECM Deposition in Airway and Possible Therapy for Remodeling ―

  2007cites this paper
• Insulin increases the expression of contractile phenotypic markers in airway smooth muscle.

  2007cites this paper
• Airway Remodeling in Asthma and Irreversible Airflow Limitation -ECM Deposition in Airway and Possible Therapy for Remodeling.

  2007cites this paper
• Airway remodeling in asthma and irreversible airflow limitation-ECM deposition in airway and possible therapy for remodeling-.

  2007cites this paper
• Effects of TGF‐β and glucocorticoids on map kinase phosphorylation, IL‐6/IL‐11 secretion and cell proliferation in primary cultures of human lung fibroblasts

  2007cites this paper
• Mucosal Remodeling in Chronic Rhinosinusitis

  2007cites this paper
• The Effect of Inhaled Budesonide and Formoterol on Bronchial Remodeling and HRCT Features in Young Asthmatics

  2007cites this paper
• Asthma treatment and asthma prevention: a tale of 2 parallel pathways.

  2007cites this paper
• Effects of TGF-beta and glucocorticoids on map kinase phosphorylation, IL-6/IL-11 secretion and cell proliferation in primary cultures of human lung fibroblasts.

  2007cites this paper
• Clinical evaluation of inhaled insulin.

  2006cites this paper
• Airway remodelling in asthma: current understanding and implications for future therapies.

  2006cites this paper
• Airway Remodelling in Asthma

  2006cites this paper
• Extracellular matrix, integrins, and mesenchymal cell function in the airways.

  2006cites this paper
• Airway remodeling in asthma and its influence on clinical pathophysiology.

  2006cites this paper
• A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro.

  2006cites this paper
• Airway remodeling from bench to bedside: current perspectives.

  2006cites this paper
• Quantification of collagen and proteoglycan deposition in a murine model of airway remodelling

  2005cites this paper
• asthmainteractions in complex traits: obesity and

  2005cites this paper
• Anti-tissue remodeling effects of corticosteroids: fluticasone propionate inhibits fibronectin expression in fibroblasts.

  2005cites this paper
• Airway remodeling in asthma: therapeutic implications of mechanisms.

  2005cites this paper
• Differential Proteomic Analysis of Bronchoalveolar Lavage Fluid in Asthmatics following Segmental Antigen Challenge*S

  2005cites this paper
• Biomarkers Predicting Response to Corticosteroid Therapy in Asthma

  2005cites this paper
• Potential role of stem cell factor in the asthma control by glucocorticoids.

  2005cites this paper
• Current developments in the physiology and management of asthma.

  2005influential citation
• Therapeutic administration of Budesonide ameliorates allergen‐induced airway remodelling

  2005cites this paper
• Role of insulin-like growth factor-I in allergen-induced airway inflammation and remodeling.

  2005cites this paper
• Beclomethasone versus placebo for chronic asthma

  2005cites this paper
• Eosinophils in repair and remodelling

  2004cites this paper
• Effects of inhaled corticosteroids on pathology in asthma and chronic obstructive pulmonary disease.

  2004cites this paper
• SMADS AS INTRACELLULAR MEDIATORS OF AIRWAY INFLAMMATION

  2004cites this paper
• Increase in laminin expression in allergic airway remodelling and decrease by dexamethasone

  2004cites this paper
• Impact of inhaled corticosteroids and leukotriene receptor antagonists on airway remodeling

  2004cites this paper
• Reduced eosinophil pro‐fibrogenic effect in severe childhood asthma compared to mild disease: An effect of corticosteroids?

  2004cites this paper
• Mycobacterial Antigens and Immunomodulation in Allergic Asthma

  2003cites this paper
• Inhaled steroids and airway remodelling in asthma.

  2003cites this paper
• Mechanisms of airway epithelial damage: epithelial-mesenchymal interactions in the pathogenesis of asthma

  2003cites this paper
• Epithelial-mesenchymal interactions in the pathogenesis of asthma

  2003cites this paper
• Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling.

  2003cites this paper